Jason Kelly, CEO of Ginkgo Bioworks, believes the future of life science R&D is autonomous, starting with the 52-cart lab he and his team have built in Boston. In this episode, I sit down with Jason to explore Ginkgo's autonomous biology lab, its collaboration with OpenAI, the POTUS-backed Genesis Mission, and where autonomous physical systems could take science next.

Hosted by Nabil Laoudji. See below for episode links, chapters, and our socials. 🙏🙌

Episode Links:

• Ginkgo Bioworks
• Jason Kelly's LinkedIn
• OpenAI x Ginkgo Cell-Free Protein Synthesis Collaboration
• Genesis Mission to Accelerate AI for Scientific Discovery
• PNNL's Anaerobic Microbial Phenotyping Platform (AMP2)
• Society for Lab Automation and Screening
• GlobalData Report: Large Pharma Drug Licensing from China

Chapters:

• (00:00) - Preview
• (01:54) - Jurassic Park and the Value of Storytelling in Science
• (04:50) - What Is the Department of Energy's AMP2 at PNNL?
• (07:17) - How Autonomous Labs Can Be Used to Run Experiments
• (11:49) - Principles of the Autonomous Lab (Waymo Analogy)
• (17:12) - Project Genesis, Competing with China in Scientific Discovery
• (23:42) - Reindustrializing America via Automation
• (37:03) - OpenAI Designing and Running Bio Experiments
• (47:17) - Advice to Frontier Labs Designing AI Intelligence for Science
• (49:24) - Ginkgo Autonomous Lab Tour
• (1:00:38) - OpenAI's Interface With Ginkgo
• (1:02:51) - Lab Scheduler Platform
• (1:16:19) - Advice for Deep Tech Startups
• (1:22:22) - Advice for Scientists and Founders Thinking About Where to Focus in Biotech
• (1:25:18) - How Research Labs Could Better Collaborate and Communicate Results
• (1:29:23) - Advantages and Challenges of Going Public
• (1:32:14) - Public Perception of Ginkgo
• (1:33:57) - How Ginkgo's Business Model Has Changed

Connect With Us:

• Our Newsletter
• Twitter
• LinkedIn
• Bluesky
• Feedback or questions

Platforms:

• YouTube
• Apple Podcasts
• Spotify Podcasts